The stock of Tandem Diabetes Care, Inc. (NASDAQ:TNDM) is a huge mover today! The stock decreased 6.80% or $4.65 during the last trading session, reaching $63.74. About 3.25 million shares traded or 148.34% up from the average. Tandem Diabetes Care, Inc. (NASDAQ:TNDM) has risen 155.35% since December 4, 2018 and is uptrending. It has outperformed by 155.35% the S&P500.
The move comes after 6 months negative chart setup for the $3.77B company. It was reported on Dec, 4 by Barchart.com. We have $58.64 PT which if reached, will make NASDAQ:TNDM worth $301.36 million less.
Analysts await Tandem Diabetes Care, Inc. (NASDAQ:TNDM) to report earnings on February, 25. They expect $-0.08 earnings per share, down 500.00 % or $0.10 from last year’s $0.02 per share. After $-0.13 actual earnings per share reported by Tandem Diabetes Care, Inc. for the previous quarter, Wall Street now forecasts -38.46 % EPS growth.
Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Ratings Coverage
Among 3 analysts covering Tandem Diabetes Care (NASDAQ:TNDM), 3 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Tandem Diabetes Care has $7600 highest and $7100 lowest target. $74’s average target is 16.10% above currents $63.74 stock price. Tandem Diabetes Care had 7 analyst reports since June 6, 2019 according to SRatingsIntel. The firm earned “Outperform” rating on Tuesday, November 5 by Robert W. Baird. UBS upgraded the shares of TNDM in report on Friday, October 4 to “Buy” rating.
More notable recent Tandem Diabetes Care, Inc. (NASDAQ:TNDM) news were published by: Fool.com which released: “3 Fast-Growing Medtech Stocks to Buy – Motley Fool” on November 08, 2019, also Finance.Yahoo.com with their article: “What Kind Of Investor Owns Most Of Tandem Diabetes Care, Inc. (NASDAQ:TNDM)? – Yahoo Finance” published on September 09, 2019, Businesswire.com published: “Tandem Diabetes Care Announces Conference Call Following Data Presentations at the ADA Scientific Sessions – Business Wire” on June 07, 2019. More interesting news about Tandem Diabetes Care, Inc. (NASDAQ:TNDM) were released by: Fool.com and their article: “Here’s Why Tandem Diabetes Care Fell 18.6% in September – Motley Fool” published on October 06, 2019 as well as Finance.Yahoo.com‘s news article titled: “Hedge Funds Have Never Been This Bullish On Tandem Diabetes Care Inc (TNDM) – Yahoo Finance” with publication date: December 03, 2019.
Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States. The company has market cap of $3.77 billion. The company's flagship product is the t:slim X2 insulin delivery system that comprises t:slim X2 pump, its disposable insulin cartridge, and an infusion set. It currently has negative earnings. It also provides t:flex insulin delivery system that includes t:flex pump, its 480-unit disposable insulin cartridge, and an infusion set; and t:slim G4 insulin delivery system, a touch-screen pump with an integrated CGM system.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.